ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 93 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $40,000 | -25.9% | 7,520 | -32.7% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +315.4% | 11,180 | +269.5% | 0.00% | – |
| Q4 2020 | $13,000 | -55.2% | 3,026 | -57.5% | 0.00% | – |
| Q3 2020 | $29,000 | +1350.0% | 7,126 | +761.7% | 0.00% | – |
| Q2 2020 | $2,000 | -85.7% | 827 | -82.4% | 0.00% | -100.0% |
| Q1 2020 | $14,000 | +180.0% | 4,704 | +367.1% | 0.00% | – |
| Q3 2019 | $5,000 | -66.7% | 1,007 | -51.9% | 0.00% | -100.0% |
| Q1 2019 | $15,000 | +150.0% | 2,093 | +176.9% | 0.00% | – |
| Q4 2018 | $6,000 | -96.3% | 756 | -90.7% | 0.00% | -100.0% |
| Q3 2018 | $162,000 | +200.0% | 8,099 | +261.4% | 0.01% | +140.0% |
| Q1 2018 | $54,000 | +74.2% | 2,241 | +51.1% | 0.01% | +66.7% |
| Q3 2017 | $31,000 | -71.6% | 1,483 | -76.2% | 0.00% | -75.0% |
| Q2 2017 | $109,000 | +505.6% | 6,233 | +487.5% | 0.01% | +500.0% |
| Q4 2016 | $18,000 | +800.0% | 1,061 | +961.0% | 0.00% | – |
| Q2 2016 | $2,000 | -97.3% | 100 | -98.1% | 0.00% | -100.0% |
| Q1 2016 | $75,000 | +56.2% | 5,177 | +82.4% | 0.01% | +120.0% |
| Q3 2015 | $48,000 | +269.2% | 2,838 | +288.8% | 0.01% | +150.0% |
| Q1 2015 | $13,000 | -61.8% | 730 | -63.2% | 0.00% | -33.3% |
| Q4 2014 | $34,000 | -37.0% | 1,983 | -33.2% | 0.00% | -57.1% |
| Q2 2014 | $54,000 | – | 2,969 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|